A preliminary analysis of the balance between Th1 and Th2 cells after CD34+ cell-selected autologous PBSC transplantation

Cytotherapy

Volumn 6, Issue 4, 2004, Pages 337-343

  Endo, Tomoyuki ^a   Sato, N ^b   Koizumi, K ^a   Nishio, M ^a   Fujimoto, K ^a   Yamamoto, S ^a   Sakai, T ^a   Bohgaki, T ^a   Sawada, K ^c   Koike, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autologous PBSC transplantation; CD34; Positive selection; Th1; Th2

Indexed keywords

CARBOPLATIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; PREDNISOLONE; RANIMUSTINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD SAMPLING; CELL MATURATION; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MALE; MALIGNANT NEOPLASTIC DISEASE; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 4544236492     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240410004907     Document Type: Article

References (29)

1. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86:390-7.
2. + peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study. J Clin Oncol 1997; 15:2288-95.
3. + cells selected by immunomagnetic procedures in patients with multiple myeloma. Bone Marrow Transplant 1998;22:957-63.
4. Holmberg LA, Boeckh M, Hooper H et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood 1999;94:4029-35.
5. + enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation. Bone Marrow Transplant 2000;26:831-6.
6. + cell-selected autologous peripheral blood stem cell transplantation. Int J Hematol 1999;70:193-9.
7. + cells: analysis of predictive factors and comparison with unselected progenitor transplants. Br J Haematol 2000;108:105-15.
8. + selected autologous peripheral blood stem cell transplantation increases the risk of cytomegalovirus infection. Haematologica 2001;86:667-8.
9. + -enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation. J Hematother Stem Cell Res 2000;9:727-36.
10. Rutella S, Pierelli L, Sica S et al. Transplantation of autologous peripheral blood progenitor cells: impact of CD34-cell selection on immunological reconstitution. Leuk Lymphoma 2001;42:1207-20.
11. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious neoplastic and inflammatory diseases. Clin Microbiol Rev 1996;9:532-62.
12. Mukai M, Bohgaki T, Kondo M et al. Changes in the T-helper cell 1/T-helper cell 2 balance of peripheral T-helper cells after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Ann Hematol 2001;80:715-21.
13. Carayol G, Bourhis JH, Guillard M et al. Quantitive analysis of T helper 1, T helper 2, and inflammatory cyrokine expression in patients after allogeneic bone marrow transplantation. Transplantation 1997;63:1307-13.
14. Tanaka J, Imamura M, Kasai M et al. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease. Bone Marrow Transplant 1997;19:571-6.
15. Openshaw P, Murphy EE, Hosken NA et al. Heterogeneity of intracellular cytokine synthesis at single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995;182:1357-67.
16. Takano H, Sawada K, Sato N et al. Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma. Leuk Lymphoma 1996;21:473-8.
17. Vesole DH, Tricot G, Jagannath S et al. Autotransplants in multiple myeloma: what have we learned? Blood 1996;88:838-47.
18. Brugger W, Frisch J, Schulz G et al. Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide, and cisplatin. J Clin Oncol 1992;10:1452-9.
19. + cells from cryopreserved peripheral blood stem cells, using a nylon-fiber syringe system and immunomagnetic microspheres. Bone Marrow Transplant 2002;26:787-93.
20. + cells using nylon-fiber syringe system and immunomagnetic microspheres. Cytotherapy 1999;1:319-27.
21. + cells, Use of immunomagnetic microspheres. Bone Marrow Transplant 1997;19:373-9.
22. Tarumi T, Sawada K, Koizumi K et al. A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 1999;34:361-71.
23. Essa S, Raghupathy R, Pacsa AS et al. Th1-type cytokines production is decreased in kidney transplant recipients with active cytomegalovirus infection. J Med Virology 2000;60:223-9.
24. Sparrelid E, Emanuel D, Fehniger T et al. Interstitial pneumonitis in bone marrow transplant recipients is associated with local production of TH2-type cytokines and lack of T cell-mediated cytotoxicity. Transplantation 1997;63:1782-9.
25. Vieira PL, de Jong EC, Wierenga EA et al. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 2000;164:4507-12.
26. Noble A, Thomas MJ, Kemeny DM. Early Th1/Th2 cell polarization in the absence of IL-4 and IL-12: T cell receptor signaling regulates the response to cytokines in CD4 and CD8 T cells. Eur J Immunol 2001;31:2227-35.
27. Magram J, Connaughton SE, Warrier RR et al. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity 1996;4:471-81.
28. Kuhn R, Rajewsky K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science 1991;254:707-10.
29. Ouyang W, Lohning M, Gao Z et al. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 2000;12:27-37.